Trials / Completed
CompletedNCT01614990
Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Garcia, Jose M., MD, PhD · Individual
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of repeated oral administration of macimorelin at different doses daily for 1 week for the treatment of cancer cachexia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Macimorelin | Subjects will receive macimorelin (1 mg/kg) and matching placebo (Powerade®) daily for 7 days. |
| DRUG | Placebo | placebo (Powerade®) daily for 7 days. |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2020-07-01
- Completion
- 2021-12-01
- First posted
- 2012-06-08
- Last updated
- 2024-03-20
- Results posted
- 2024-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01614990. Inclusion in this directory is not an endorsement.